Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Mortality risk estimation for autistic older adults: comparing novel machine-learning derived weights versus standard weights for the Charlson Comorbidity Index
Madison Blake
,
Melica Nikahd
,
J Madison Hyer
,
Brian W Patterson
,
Bethany J Wolf
,
Lauren Bishop
, and
Brittany N Hand
Journal of Comparative Effectiveness Research
29 Jul 2026
Validity of HINT-8 in evaluating health-related quality of life among cervical cancer patients
Ah-Yeon Lee
,
Soo Hyeon Lee
,
Min-Ju Kim
,
Ji-Eun An
,
Gyeong-U Hong
,
Woo-Jeong Sim
,
Hyunji Lim
,
Tae-Wook Kong
,
Byung Su Kwon
,
Sung Taek Park
,
Kyeong A So
,
Won Moo Lee
,
Jung-Yun Lee
,
Dae Hoon Jeong
,
Min Chul Choi
,
Youn Jin Choi
,
Jae-Kwan Lee
,
Tae-Hwe Heo
,
Kyung-Jin Min
, and
Su-Yeon Yu
Journal of Comparative Effectiveness Research
24 Jul 2026
Examining the affect of global drug pricing policies on US patient access and pharmaceutical innovation
The Evidence Base
29 Jul 2026
Designing trustworthy RWE: How policy, data infrastructure, and AI shape real‑world impact
The Evidence Base
29 Jul 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
29 Jul 2026
Designing trustworthy RWE: How policy, data infrastructure, and AI shape real‑world impact
27 Jul 2026
Critical Path Institute expands rare disease data platform through Across Healthcare partnership
24 Jul 2026
ISPOR white paper recommends coordinated evidence generation across European healthcare decision-making
28 Jul 2026
Another JCA initiated as daraxonrasib enters EU HTA process alongside EMA phased review
24 Jul 2026
ISPOR white paper recommends coordinated evidence generation across European healthcare decision-making
24 Jul 2026
Flatiron Health brings Scottish oncology data into global real-world evidence network
15 Jul 2026
Following the patient journey: How connected data and evolving methods are reshaping real-world evidence
15 Jul 2026
ISPOR Special Task Force introduces IMPACT framework for value-based healthcare implementation
14 Jul 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in June 2026
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
29 Jul 2026
Examining the affect of global drug pricing policies on US patient access and pharmaceutical innovation
29 Jul 2026
Designing trustworthy RWE: How policy, data infrastructure, and AI shape real‑world impact
28 Jul 2026
Another JCA initiated as daraxonrasib enters EU HTA process alongside EMA phased review
27 Jul 2026
Critical Path Institute expands rare disease data platform through Across Healthcare partnership